GlassScriptPhysician profile
Sommer Hammoud
NPI 1902017072
$237,769.14
in general payments reported to CMS, 2019-2025
11 companies · $130K in 2025
The $130K reported for 2025 was more than what 98% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,920 · 2020: $16.97 · 2021: $124 · 2022: $9,793 · 2023: $36K · 2024: $58K · 2025: $130K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $178K · Consulting Fee: $30K · Travel and Lodging: $13K · Food and Beverage: $3,487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $178,075.92 |
| Consulting Fee | $30,385.45 |
| Travel and Lodging | $12,966.47 |
| Food and Beverage | $3,487.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $231,054.87 | 2019-2025 | Arthrex, Knee & Hip Implants Collateral Ligament, Knee & Hip Implants Meniscal Repair Fiberstitch |
| Liberty Surgical INC. | $2,341.45 | 2019-2022 | |
| Paladin Technology Solutions | $2,213.86 | 2022-2025 | |
| Smith+Nephew, INC. | $1,581.15 | 2022-2023 | Spatial Frame, Bone Anchors With Arthroscopic Delivery System, Healicoil |
| Bodycad USA Corp | $285.64 | 2024-2025 | Fine Osteotomy, Fine Osteotomy |
| Stryker Corporation | $124.01 | 2021 | |
| Eclipse Technology Solutions INC. | $63.08 | 2022-2025 | |
| Bioventus LLC | $41.14 | 2024 | Durolane |
| Convatec INC. | $23.54 | 2024 | |
| Medtronic, INC. | $22.81 | 2025 | Intellis Adaptivestim |
| Depuy Synthes Sales INC. | $17.59 | 2023 | Monovisc, Orthovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sommer Hammoud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.